Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB064A | — |
Menveo only liquid portion given; Menveo only liquid portion given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 20-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB064A, expiry date 31-DEC-2025) for prophylaxis. On 07-AUG-2025, the patient received Menveo. On 07-AUG-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Menveo only liquid portion given) and inappropriate dose of vaccine administered (Verbatim: Menveo only liquid portion given). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date:07-AUG-2025 The pharmacist called to report only the liquid portion of the Menveo vaccine was administered to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered